In recent years, several studies have investigated the potential role of Nrf2 protein, which plays critical roles in carcinogenesis, tumor progression and chemotherapy resistance (35, 42, 43), but not before B-ALL. Here, NFE2L2 is linked to acute lymphoblastic leukemia.